Valiant Capital reports 5.3% stake in Core Scientific
Core Scientific, Inc. has a significant shareholder position reported by Valiant Capital entities and Christopher R. Hansen in an amended Schedule 13G filing.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Core Scientific, Inc. has a significant shareholder position reported by Valiant Capital entities and Christopher R. Hansen in an amended Schedule 13G filing. Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Hansen each report beneficial ownership of 16,956,009 shares of Core Scientific common stock, representing 5.3% of the class, based on 321,340,441 shares outstanding as of July 23, 2026.
The shares are held by private investment funds advised by Valiant, which have the right to receive dividends and sale proceeds. Voting and dispositive power over all 16,956,009 shares is reported as shared, with no sole voting or dispositive power. The filers state the securities were not acquired or held for the purpose of changing or influencing control of Core Scientific.
Key Figures
Shares beneficially owned:16,956,009 sharesPercent of class:5.3%Shares outstanding baseline:321,340,441 shares+2 more
5 metrics
Shares beneficially owned16,956,009 sharesCore Scientific common stock reported by each of VCM, VCM LLC and Christopher R. Hansen
Percent of class5.3%Ownership percentage of Core Scientific common stock for each reporting person
Shares outstanding baseline321,340,441 sharesCore Scientific common stock outstanding as of July 23, 2026 used to calculate 5.3%
Sole voting power0 sharesNo sole voting power reported by any of the reporting persons
Shared voting power16,956,009 sharesShares over which reporting persons share voting power
"Each reporting person also disclaims beneficial ownership of Common Stock except to the extent"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting powerfinancial
"Shared Voting Power 16,956,009.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 16,956,009.00"
Schedule 13Gregulatory
"Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Investment Company Act of 1940regulatory
"An investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Core Scientific (CORZ) does Valiant Capital report?
Valiant Capital and Christopher R. Hansen report beneficial ownership of 16,956,009 Core Scientific shares, representing 5.3% of the common stock, based on 321,340,441 shares outstanding as of July 23, 2026.
Who are the reporting persons in this Core Scientific (CORZ) Schedule 13G/A?
The reporting persons are Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Christopher R. Hansen. Valiant advises private investment funds that hold the Core Scientific common stock for the benefit of their investors.
How much voting power over Core Scientific (CORZ) shares does Valiant report?
The filers report 0 shares with sole voting power and 16,956,009 shares with shared voting power. They likewise report 0 shares with sole dispositive power and 16,956,009 shares with shared dispositive power.
Are any individual Valiant funds over 5% owners of Core Scientific (CORZ)?
No individual fund exceeds the 5% threshold. The filing states that no individual Fund's holdings of Core Scientific common stock are more than five percent of the outstanding common stock; the 5.3% relates to aggregated fund holdings.
Is Valiant’s Core Scientific (CORZ) stake intended to influence control of the company?
The filers certify that the Core Scientific securities were not acquired and are not held for the purpose of changing or influencing control of the issuer, and not in connection with any transaction having that purpose or effect.
On what share count is Valiant’s 5.3% Core Scientific (CORZ) ownership based?
The reported 5.3% ownership is calculated using 321,340,441 Core Scientific common shares outstanding as of July 23, 2026, as reported in Core Scientific’s Form 10-Q for the quarter ended June 30, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Core Scientific, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
21874A106
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
21874A106
1
Names of Reporting Persons
Valiant Capital Management, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
16,956,009.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
16,956,009.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
16,956,009.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
IA, PN
Comment for Type of Reporting Person: Percentage calculated based on 321,340,441 shares of Common Stock outstanding as of July 23, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
21874A106
1
Names of Reporting Persons
Valiant Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
16,956,009.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
16,956,009.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
16,956,009.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
HC, OO
Comment for Type of Reporting Person: Percentage calculated based on 321,340,441 shares of Common Stock outstanding as of July 23, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
21874A106
1
Names of Reporting Persons
Christopher R. Hansen
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
16,956,009.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
16,956,009.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
16,956,009.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: Percentage calculated based on 321,340,441 shares of Common Stock outstanding as of July 23, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2026.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Core Scientific, Inc.
(b)
Address of issuer's principal executive offices:
838 Walker Road, Suite 21-2105, Dover, DE 19904
Item 2.
(a)
Name of person filing:
Valiant Capital Management, L.P., a Delaware limited partnership ("VCM")
Valiant Capital Management, LLC, a Delaware limited liability company ("VCM LLC")
Christopher R. Hansen
VCM is the investment adviser and general partner of private investment funds (collectively, the "Funds"). VCM LLC is the general partner of VCM. Mr. Hansen is the control person of VCM and VCM LLC. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein.
(b)
Address or principal business office or, if none, residence:
394 Pacific Avenue, Floor 4, San Francisco, CA 94111
(c)
Citizenship:
See Item 4 of the cover sheet for each reporting person
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
21874A106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
VCM: 16,956,009
VCM LLC: 16,956,009
Christopher R. Hansen: 16,956,009
(b)
Percent of class:
VCM: 5.3%
VCM LLC: 5.3%
Christopher R. Hansen: 5.3%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
VCM: 0
VCM LLC: 0
Christopher R. Hansen: 0
(ii) Shared power to vote or to direct the vote:
VCM: 16,956,009
VCM LLC: 16,956,009
Christopher R. Hansen: 16,956,009
(iii) Sole power to dispose or to direct the disposition of:
VCM: 0
VCM LLC: 0
Christopher R. Hansen: 0
(iv) Shared power to dispose or to direct the disposition of:
VCM: 16,956,009
VCM LLC: 16,956,009
Christopher R. Hansen: 16,956,009
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The Funds hold the Common Stock for the benefit of their investors and have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. No individual Fund's holdings of Common Stock are more than five percent of the outstanding Common Stock.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Valiant Capital Management, L.P.
Signature:
/s/ Michaela Beckman
Name/Title:
Chief Compliance Officer
Date:
08/14/2026
Valiant Capital Management, LLC
Signature:
/s/ Michaela Beckman
Name/Title:
Chief Compliance Officer
Date:
08/14/2026
Christopher R. Hansen
Signature:
/s/ Christopher R. Hansen
Name/Title:
Reporting person
Date:
08/14/2026
Exhibit Information
Exhibit 99 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G
